Condition
Biliary Tract Cancer (CCA) clinical trials and research
Research outlook What's coming for Cholangiocarcinoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Biliary Tract Cancer (CCA) clinical trials that are recruiting, at sites in 2 countries (most in China (1), United Kingdom (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
In-depth characterisation of biliary strictures and hepato‑pancreato‑biliary focal lesions to support new diagnostic technologies
This project will collect detailed imaging and tissue data from adults with suspected bile duct, liver, pancreatic, or gallbladder lesions to help develop and test better diagnostic tools.
-
Adebrelimab with apatinib plus gemcitabine–cisplatin for initially unresectable biliary tract cancer
This trial tests whether adding the immunotherapy adebrelimab and the targeted drug apatinib to standard chemotherapy helps people with newly diagnosed, unresectable biliary tract cancer.
Related topics
Quick answers
How many Biliary Tract Cancer (CCA) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.